mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.04 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.05 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.05 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.05 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.05 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.05 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.05 |